Title: AVENIO ctDNA Clinical Research Story: Surveillance & Monitoring
Speaker: Timothy R. Schwartz, Ph.D., Senior Scientific Affairs Manager,
Medical and Scientific Affairs - US, Roche Diagnostics Corporation
Date: Wednesday, November 6, 2019
Time: 11:00 am - 11:50 am
Room: 327 - 329
Description: There are multiple challenges present in the disease monitoring of solid tumors; treatment options are available but broadly-applicable disease monitoring is not yet established. The AVENIO NGS Surveillance kit enabled by CAPP-Seq technology is proven to be feasible in ctDNA-based monitoring of lung and colorectal cancers, moving toward ctDNA-guided disease management. This workshop will discuss clinical research results using the AVENIO somatic oncology kits, minimal residual disease (MRD) detection through ctDNA analysis, disease monitoring starting with and without matched tissue biopsies, and future opportunities for AVENIO assays in clinical cancer research.